Soluble guanylate cyclase stimulators and their potential use: a patent review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble guanylate cyclase stimulators and their potential use: a patent review

Published:2021-01-04 Issue:3 Volume:31 Page:203-222
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Sandner Peter¹²,Vakalopoulos Alexandros¹,Hahn Michael G.¹,Stasch Johannes-Peter¹³,Follmann Markus¹

Affiliation:

1. Bayer AG, Pharmaceuticals Drug Discovery, Institutes of Cardiology and Medicinal Chemistry, Wuppertal, Germany

2. Hannover Medical School, Institute of Pharmacology, Hannover, Germany

3. cMartin Luther University Halle, Institute of Pharmacy, Halle, Halle, Germany

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1866538

Reference97 articles.

1. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

2. The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators

3. Correction to: Soluble Guanylate Cyclase Stimulators and Activators

4. Nitric oxide signalling in cardiovascular health and disease

5. New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats;Hypertension Research;2024-09-09

2. Promising therapeutic targets for the treatment of urine storage dysfunction: what’s the status?;Expert Opinion on Therapeutic Targets;2024-04-02

3. Molecular cardiopharmacology and therapeutics-II;Biochemical and Molecular Pharmacology in Drug Discovery;2024

4. Vericiguat alleviates ventricular remodeling and arrhythmias in mouse models of myocardial infarction via CaMKII signaling;Life Sciences;2023-12

5. Pharmacotherapy in patients with vasomotor disorders;IJC Heart & Vasculature;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3